SD BioSensor Inc., an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company's products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters. The company was founded in 2010 and is headquartered in Suwon, South Korea.

Tae Young  Heo

Nombre	Capitalización
ConvaTec Group Plc	0M
Spineway SA	0M
Jiangsu Apon Medical Technology Co., Ltd.	0M
Bausch + Lomb Corporation	0M
Ypsomed Holding AG	0M
InfuSystem Holdings, Inc.	0M
INSPECS Group plc	0M
HOYA Corporation	0M
Alcon Inc.	0M
Nipro Corporation	0M

SD BioSensor, Inc

SD BioSensor, Inc Lista de competidores

Principales competidores